FR1332M - Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine. - Google Patents

Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine.

Info

Publication number: FR1332M
Authority: FR; France
Prior art keywords: oxobutyl; pyrazolidine; dioxo; diphenyl; therapeutic applications
Prior art date: 1961-08-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR869714A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Spofa Sdruzeni Podniku Pro Zdravotnickou Vyrobu

Spofa Vereinigte Pharma Werke

Original Assignee

Spofa Sdruzeni Podniku Pro Zdravotnickou Vyrobu

Spofa Vereinigte Pharma Werke

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1961-08-01

Filing date

1961-08-01

Publication date

1962-05-28

1961-08-01 Application filed by Spofa Sdruzeni Podniku Pro Zdravotnickou Vyrobu, Spofa Vereinigte Pharma Werke filed Critical Spofa Sdruzeni Podniku Pro Zdravotnickou Vyrobu

1961-08-01 Priority to FR869714A priority Critical patent/FR1332M/fr

1962-05-28 Application granted granted Critical

1962-05-28 Publication of FR1332M publication Critical patent/FR1332M/fr

Status Active legal-status Critical Current

Links

LGYTZKPVOAIUKX-UHFFFAOYSA-N kebuzone Chemical compound O=C1C(CCC(=O)C)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 LGYTZKPVOAIUKX-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- C07D231/32—Oxygen atoms
- C07D231/36—Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)

FR869714A 1961-08-01 1961-08-01 Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine. Active FR1332M (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
FR869714A FR1332M (fr)	1961-08-01	1961-08-01	Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR869714A FR1332M (fr)	1961-08-01	1961-08-01	Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine.

Publications (1)

Publication Number	Publication Date
FR1332M true FR1332M (fr)	1962-05-28

Family

ID=87804008

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR869714A Active FR1332M (fr)	1961-08-01	1961-08-01	Applications thérapeutiques de la 1,2-diphényl-3,5-dioxo-4-(γ-oxobutyl)-pyrazolidine.

Country Status (1)

Country	Link
FR (1)	FR1332M (fr)

1961
- 1961-08-01 FR FR869714A patent/FR1332M/fr active Active

Similar Documents

Publication	Publication Date	Title
CH445023A (de)	1967-10-15	Haarwaschmittel
BE622809A (fr)	1963-03-25	Dérivés de thiaxanthène.
DK102884C (da)	1965-10-18	Insektbekæmpelsesmiddel.
FR1514M (fr)	1962-10-08	Nouvelles préparations thérapeutiques.
FI45380C (fi)	1972-05-10	Ristiuraruuvi.
FR1137M (fr)	1962-02-19	Applications thérapeutiques de cyclohexyl-phénols.
FR6247M (fr)	1968-09-16	Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
DK105952C (da)	1966-11-28	Insektbekæmpelsesmiddel.
DK102380C (da)	1965-08-16	Opløsningshærdet zink-kobber-titan-legering.
BE617781A (fr)	1962-11-19	Fongicides.
FR2281M (fr)	1964-01-20	Esters de 17α-ethynylestr-5(10)-ene-3β,17β-diol.
FR2700M (fr)	1964-08-03	Diphénylalkylamines substituées.
FR2535M (fr)	1964-05-19	Diphénylalkénylamines substituées.
FR2315M (fr)	1964-02-03	Propynylamines substituées.
FR2302M (fr)	1964-01-27	Androstenes-5 substitués.
FR1373M (fr)	1962-06-25	Composition thérapeutique.
FR1224M (fr)	1962-04-02	Traitement homéoflore des glandes sébacées.
FR3265M (fr)	1965-04-26	Diluant pharmaceutique.
FR2156M (fr)	1963-11-18	Nouvelles compositions thérapeutiques.
FR2224M (fr)	1963-12-23	Aminoptéridines substituées.
BE618426A (fr)	1962-10-01	3-Méthoxyméthyl-1-(5-nitrofurfurylidèneamino) hydantoïne
FR2237M (fr)	1963-12-30	Nouvelles applications thérapeutiques de nouveaux stéroides du type androstene-4,trione-3,11,17,oxime-17.
FR1173M (fr)	1962-03-12	Compositions thérapeutiques.
FR37F (fr)	1963-10-04	Agent thérapeutique.
FR2324M (fr)	1964-02-10	Nouvelles applications thérapeutiques des épithio-16, 17 stéroides.